Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6595 |
Moexipril hydrochloride
莫昔普利盐酸盐,Moexipril HCl,RS-10085,SPM 925,CI-925 |
Apoptosis; RAAS | Apoptosis; Endocrinology/Hormones |
Moexipril hydrochloride (Moexipril HCl) 是一种有口服活性的,不含巯基的血管紧张素转化酶抑制剂,可治疗高血压和充血性心力衰竭。 | |||
T70884 | Moexipril methyl ester | ||
Moexipril methyl ester is a long-acting, non-sulfhydryl angiotensine-converting enzyme inhibitor. | |||
T70883 |
Moexipril-d5
|
||
Moexipril-d5 intended for use as an internal standard for the quantification of moexipril by GC- or LC-MS. Moexipril is a prodrug form of the angiotensin converting enzyme (ACE) inhibitor moexiprilat. It is converted to moexiprilat in vivo by side chain ester hydrolysis. Moexipril inhibits ACE in a cell-free assay (IC50 = 2.7 µM for the rabbit enzyme). It also inhibits phosphodiesterase 4 (IC50s = 38, 160, and 230 µM for PDE4B2, PDE4A5 and PDE4D5, respectively). Moexipril (0.1-30 mg/kg per day) ... | |||
T63377 |
Moexipril
|
||
Moexipril 是口服具有活力的血管紧张素转换酶 (ACE) 抑制剂。Moexipril 易于透过脂质膜,靶向血浆和组织ACE,改善内皮功能障碍,具有神经保护活性,能够用于研究心血管疾病。 |